125 related articles for article (PubMed ID: 36282060)
1. What Is a Normal Testosterone Level for Young Men? Rethinking the 300 ng/dL Cutoff for Testosterone Deficiency in Men 20-44 Years Old.
Zhu A; Andino J; Daignault-Newton S; Chopra Z; Sarma A; Dupree JM
J Urol; 2022 Dec; 208(6):1295-1302. PubMed ID: 36282060
[TBL] [Abstract][Full Text] [Related]
2. Human Chorionic Gonadotropin monotherapy for the treatment of hypogonadal symptoms in men with total testosterone > 300 ng/dL.
Madhusoodanan V; Patel P; Lima TFN; Gondokusumo J; Lo E; Thirumavalavan N; Lipshultz LI; Ramasamy R
Int Braz J Urol; 2019; 45(5):1008-1012. PubMed ID: 31408289
[TBL] [Abstract][Full Text] [Related]
3. Factors influencing prostate-specific antigen response among men treated with testosterone therapy for 6 months.
Morgentaler A; Benesh JA; Denes BS; Kan-Dobrosky N; Harb D; Miller MG
J Sex Med; 2014 Nov; 11(11):2818-25. PubMed ID: 25131184
[TBL] [Abstract][Full Text] [Related]
4. Testosterone replacement therapy among elderly males: the Testim Registry in the US (TRiUS).
Bhattacharya RK; Khera M; Blick G; Kushner H; Miner MM
Clin Interv Aging; 2012; 7():321-30. PubMed ID: 22956867
[TBL] [Abstract][Full Text] [Related]
5. Changes in prostate specific antigen in hypogonadal men after 12 months of testosterone replacement therapy: support for the prostate saturation theory.
Khera M; Bhattacharya RK; Blick G; Kushner H; Nguyen D; Miner MM
J Urol; 2011 Sep; 186(3):1005-11. PubMed ID: 21788049
[TBL] [Abstract][Full Text] [Related]
6. Impaired sleep is associated with low testosterone in US adult males: results from the National Health and Nutrition Examination Survey.
Patel P; Shiff B; Kohn TP; Ramasamy R
World J Urol; 2019 Jul; 37(7):1449-1453. PubMed ID: 30225799
[TBL] [Abstract][Full Text] [Related]
7. Absent Diurnal Variation in Serum Testosterone in Young Men with Testosterone Deficiency.
Shlykova N; Davidson E; Krakowsky Y; Bolanos J; Traish A; Morgentaler A
J Urol; 2020 Apr; 203(4):817-823. PubMed ID: 31670607
[TBL] [Abstract][Full Text] [Related]
8. Long acting testosterone undecanoate therapy in men with hypogonadism: results of a pharmacokinetic clinical study.
Morgentaler A; Dobs AS; Kaufman JM; Miner MM; Shabsigh R; Swerdloff RS; Wang C
J Urol; 2008 Dec; 180(6):2307-13. PubMed ID: 18930255
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of prostate cancer among hypogonadal men with prostate-specific antigen levels of 4.0 ng/mL or less.
Morgentaler A; Rhoden EL
Urology; 2006 Dec; 68(6):1263-7. PubMed ID: 17169647
[TBL] [Abstract][Full Text] [Related]
10. Effects of aromatase inhibition in elderly men with low or borderline-low serum testosterone levels.
Leder BZ; Rohrer JL; Rubin SD; Gallo J; Longcope C
J Clin Endocrinol Metab; 2004 Mar; 89(3):1174-80. PubMed ID: 15001605
[TBL] [Abstract][Full Text] [Related]
11. Testosterone replacement for hypogonadism after treatment of early prostate cancer with brachytherapy.
Sarosdy MF
Cancer; 2007 Feb; 109(3):536-41. PubMed ID: 17183557
[TBL] [Abstract][Full Text] [Related]
12. Analysis of diurnal variation in serum testosterone levels in men with symptoms of testosterone deficiency.
Novaes LF; Flores JM; Benfante N; Schofield E; Katz DJ; Nelson CJ; Mulhall JP
J Sex Med; 2024 Apr; 21(5):408-413. PubMed ID: 38481019
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of Non-Testosterone-Based Treatment in Hypogonadal Men: A Review.
Raheem OA; Chen T; Akula KP; Greenberg J; Le TV; Chernobylsky D; Sikka SC; Walsh TJ
Sex Med Rev; 2021 Jul; 9(3):381-392. PubMed ID: 33933392
[TBL] [Abstract][Full Text] [Related]
14. Harmonized Reference Ranges for Circulating Testosterone Levels in Men of Four Cohort Studies in the United States and Europe.
Travison TG; Vesper HW; Orwoll E; Wu F; Kaufman JM; Wang Y; Lapauw B; Fiers T; Matsumoto AM; Bhasin S
J Clin Endocrinol Metab; 2017 Apr; 102(4):1161-1173. PubMed ID: 28324103
[TBL] [Abstract][Full Text] [Related]
15. Subjective sexual response to testosterone replacement therapy based on initial serum levels of total testosterone.
Reyes-Vallejo L; Lazarou S; Morgentaler A
J Sex Med; 2007 Nov; 4(6):1757-62. PubMed ID: 17087806
[TBL] [Abstract][Full Text] [Related]
16. Workplace noise exposure and serum testosterone in men enrolled in the 1999-2004 National Health and Nutrition Examination Survey.
Dzhambov AM
Arh Hig Rada Toksikol; 2016 Sep; 67(3):247-258. PubMed ID: 27749261
[TBL] [Abstract][Full Text] [Related]
17. Characterising the safety of clomiphene citrate in male patients through prostate-specific antigen, haematocrit, and testosterone levels.
Chandrapal JC; Nielson S; Patel DP; Zhang C; Presson AP; Brant WO; Myers JB; Hotaling JM
BJU Int; 2016 Dec; 118(6):994-1000. PubMed ID: 27226135
[TBL] [Abstract][Full Text] [Related]
18. Testosterone supplementation versus clomiphene citrate for hypogonadism: an age matched comparison of satisfaction and efficacy.
Ramasamy R; Scovell JM; Kovac JR; Lipshultz LI
J Urol; 2014 Sep; 192(3):875-9. PubMed ID: 24657837
[TBL] [Abstract][Full Text] [Related]
19. Predicting biochemical response to clomiphene citrate in men with hypogonadism.
Mazzola CR; Katz DJ; Loghmanieh N; Nelson CJ; Mulhall JP
J Sex Med; 2014 Sep; 11(9):2302-7. PubMed ID: 24902614
[TBL] [Abstract][Full Text] [Related]
20. The effect of hypogonadism and testosterone-enhancing therapy on alkaline phosphatase and bone mineral density.
Dabaja AA; Bryson CF; Schlegel PN; Paduch DA
BJU Int; 2015 Mar; 115(3):480-5. PubMed ID: 25046796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
